Stock should be about 2 bucks. The Europe equivalent of FDA approval is worth 100 of millions in future contracts. As I have said for months. The public is beyond stupid on this stock. If they had a brain, this stock would have been 3+ bucks 2 months ago. Better for us who continue to buy shares. Doesn't matter though. The major pharm company who buys this stock will do so at a hefty price because they know they will corner a multi billion dollar market.
News 
Market Data 
Discover 
